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Compared to the general population, severe psychiatric 
disorders are associated with an increased mortality, which 
can largely be explained by a high incidence of somatic 
comorbidities, unhealthy lifestyle, low physical activity 
and increased rate of suicides [1]. For example, schizophre-
nia patients have a higher prevalence of the metabolic syn-
drome than the general population, with a two- to threefold 
increased risk for cardiovascular diseases (CVDs) resulting 
in increased cardiac mortality [2]. This leads to an estimated 
reduction in life expectancy of nearly 10–15 years com-
pared to the general population. The metabolic syndrome 
is defined as a combination of increased waist circumfer-
ence and two of the following criteria: high blood pressure, 
elevated triglycerides, low high-density lipoprotein (HDL) 
cholesterol and elevated fasting glucose, by the International 
Diabetes Federation. It is also defined by the Adult Treat-
ment Panel III (ATP III) of the National Cholesterol Educa-
tion and the adapted Adult Treatment Panel III (ATP III-A) 
of the American Heart Association, which require 3 criteria 
to be fulfilled [1].
The high prevalence of the metabolic syndrome has an 
impact on clinical outcome in patients with severe mental 
disorders. Using the IDF and ATP III criteria, 30.1% of psy-
chiatric inpatients were found to be overweight, 17.2% obese 
and about 25% fulfilled criteria for metabolic syndrome. In 
fact, 3.8% had (pre)diabetes, 8.3% had a moderate and 1.9% 
a high CVD score [3]. In a follow-up study of schizophrenia 
patients, prevalence of the metabolic syndrome increased 
substantially after a mean of 8 years and the nutritional sta-
tus was found to play a major role [4]. In patients with psy-
chosis, high cholesterol and low-density lipoprotein (LDL) 
scores showed significant associations with depression [5]; 
while, an increase in HDL levels was related to improvement 
in verbal learning [6]. In trauma-exposed women, higher 
body mass index was associated with less cardiac output and 
heart rate recovery from a stress task, suggesting that PTSD 
recovery may be mediated by body mass index [7].
A position statement from the European Psychiatric 
Association (EPA) recommends the use of physical activity 
in routine clinical care of severe mental disorders such as 
schizophrenia and major depression to improve psychiat-
ric and medical outcomes [8]. Aerobic exercise is affecting 
multiple organs and may positively influence neuroplastic 
processes as well as factors of the metabolic syndrome [9]. 
Therefore, current guidelines such as the German S3 Schiz-
ophrenia Guideline recommend its application in severe 
mental disorders. Further research is required on the neu-
robiological mechanisms by which aerobic exercise exerts 
its protective effects on factors of the metabolic syndrome 
and cognition. Furthermore, it should be investigated which 
mode and what duration of training are expected to have 
beneficial effects on cardiorespiratory fitness, metabolic 
parameters and symptoms of severe mental disorders [10].
Acknowledgments Open Access funding provided by Projekt DEAL.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
References
 1. Schmitt A, Maurus I, Rossner MJ, Röh A, Lembeck M, von 
Wilmsdorff M, Takahashi S, Rauchmann B, Keeser D, Hasan 
 * Andrea Schmitt 
 Andrea.Schmitt@med.uni-muenchen.de
1 Department of Psychiatry and Psychotherapy, University 
Hospital, LMU Munich, Nußbaumstrasse 7, 80336 Munich, 
Germany
2 Institute of Psychiatric Phenomics and Genomics, University 
Hospital, LMU Munich, Nußbaumstrasse 7, 80336 Munich, 
Germany
500 European Archives of Psychiatry and Clinical Neuroscience (2020) 270:499–500
1 3
A, Malchow B, Falkai P (2018) Effects of aerobic exercise on 
metabolic syndrome, cardiorespiratory fitness, and symptoms 
in schizophrenia include decreased mortality. Front Psychiatry 
9:690. https ://doi.org/10.3389/fpsyt .2018.00690 
 2. Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA 
(2014) Increased mortality in schizophrenia due to cardiovascu-
lar disease—a non-systematic review of epidemiology, possible 
causes, and interventions. Front Psychiatry 5:137. https ://doi.
org/10.3389/fpsyt .2014.00137 
 3. Barton BB, Zagler A, Engl K, Rihs L, Musil R (2020) Preva-
lence of obesity, metabolic syndrome, diabetes and risk of cardio-
vascular disease in a psychiatric inpatient sample: results of the 
Metabolism in Psychiatry (MiP) Study. Eur Arch Psychiatry Clin 
Neurosci. https ://doi.org/10.1007/s0040 6-019-01043 -8
 4. Yoca G, Yağcıoğlu AEA, Eni N, Karahan S, Türkoğlu I, Yıldız 
EA, Mercanlıgil SM, Yazıcı MK (2020) A follow-up study of 
metabolic syndrome in schizophrenia. Eur Arch Psychiatry Clin 
Neurosci. https ://doi.org/10.1007/s0040 6-019-01016 -x
 5. Gohar SM, Dieset I, Steen NE, Mørch RH, Iversen TS, Steen VM, 
Andreassen OA, Melle I (2019) Association between serum lipid 
levels, osteoprotegerin and depressive symptomatology in psy-
chotic disorders. Eur Arch Psychiatry Clin Neurosci 269(7):795–
802. https ://doi.org/10.1007/s0040 6-018-0897-z
 6. Gjerde PB, Simonsen CE, Lagerberg TV, Steen NE, Ueland 
T, Andreassen OA, Steen VM, Melle I (2020) Improvement in 
verbal learning over the first year of antipsychotic treatment is 
associated with serum hdl levels in a cohort of first episode psy-
chosis patients. Eur Arch Psychiatry Clin Neurosci 270(1):49–58. 
https ://doi.org/10.1007/s0040 6-019-01017 -w
 7. Kibler JL, Ma M, Llabre MM (2020) Body mass index in rela-
tion to cardiovascular recovery from psychological stress among 
trauma-exposed women. Eur Arch Psychiatry Clin Neurosci. https 
://doi.org/10.1007/s0040 6-019-01054 -5
 8. Stubbs B, Vancampfort D, Hallgren M, Firth J, Brand S, Cordes 
J, Malchow B, Gerber M, Schmitt A, Correll C, DeHert M, 
Gaughran F, Schneider F, Veronese N, Solmi M, Falkai P, Möller 
H-J, Kahl KG (2018) EPA guidance on physical activity as a treat-
ment for severe mental illness: a meta-review of the evidence 
and Position Statement from the European Psychiatric Asso-
ciation (EPA), supported by the International Organization of 
Physical Therapists in Mental Health (IOPTMH). Eur Psychiatry 
54:124–144
 9. Maurus I, Hasan A, Röh A, Takahashi S, Rauchmann B, Keeser D, 
Malchow B, Schmitt A, Falkai P (2019) Neurobiological effects 
of aerobic exercise, with a focus on patients with schizophrenia. 
Eur Arch Psychiatry Clin Neurosci 269(5):499–515
 10. Schmitt A, Reich-Erkelenz D, Hasan A, Falkai P (2019) Aerobic 
exercise in mental disorders: from basic mechanisms to treat-
ment recommendations. Eur Arch Psychiatry Clin Neurosci 
269(5):483–484
